In-depth coverage of the UK’s exit from the EU, and what it means to pharma and healthcare.
Japanese pharma getting frustrated with NICE
Parallel Trade 2018
Government must strike science R&D deal with EU, says ABPI
But BMA warns more must be done to prevent Brexit brain-drain.
Health and business secretaries commit to close working with EMA
How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.
Saratha Rajeswaran will lead government affairs team